Immunostimulatory nucleic acid molecules
US7723022B2 · kind B2 · utility
32Cited by
49References
7Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 14, 2005 |
| Grant date | May 25, 2010 |
| Priority date | — |
| Expiry date | Jun 3, 2026 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Nucleic acids containing unmethylated CpG dinucleotides and therapeutic utilities based on their ability to stimulate an immune response and to redirect a Th2 response to a Th1 response in a subject are disclosed. Methods for treating atopic diseases, including atopic dermatitis, are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.